Publikationer

Vetenskapliga artiklar

  1. Scandinavian Quality Register for Thyroid- and Parathyroid Surgery: Audit of surgery for primary hyperparathyroidism. Langenbeck’s Arch Surg 392:445-451, 2007 Bergenfelz A, Jansson S, Mårtensson H, Reihnér E, Wallin G, Kristoffersson A, Lausen I.
  2. Complications to thyroid surgery: Results as reported in a database from a multi-center audit comprising 3660 patients. Langenbeck’s Archives of Surgery, 393 (5):667-673, 2008 Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, and Lausen I.
  3. Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Bergenfelz AO, Wallin G, Jansson S, Eriksson H, Mårtensson H, Christiansen P, Reihnér E. Langenbeck’s Arch Surg. 2011 Jan;396(1):83-90. doi: 10.1007/s00423-010-0724-0. PMID: 21061130.
  4. Diagnostiken av knöl i tyreoidea uppvisar kvalitetsbrister. Nationella riktlinjer bör införas Läkartidningen 2011; 108: 664–8 Jansson S, Eggertsen R, Grunditz T, Mölne J, Nyström E, Reihnér E, Rostgård Christiansen L, Tennvall J.
  5. Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients. Langenbeck’s Arch Surg 394(5):851-60, 2009 Bergenfelz AO, Jansson SK, Wallin GK, Mårtensson HG, Rasmussen L, Eriksson HL, Reihnér E.
  6. Risk factors for medically treated hypocalcemia after surgery for Graves’ disease: a Swedish multicenter study of 1,157 patients. Hallgrimsson P, Nordenström E, Almquist M, Bergenfelz AO. World J Surg. 2012 Aug; 36 (8):1933-42.
  7. Determinants for malignancy in surgically treated adrenal lesions. Wright L, Nordenström E, Almquist M. Langenbeck’s Arch Surg. 2012 Feb; 397 (2):217-23. Epub 2011 Sep 21.
  8. Vitamin D status in patients operated for Primary Hyperparathyroidism comparison of patients from Southern and Northern Europe. Erik Nordenström, Antonio Sitges Serra, Joan J. Sancho, Mark Thier, Martin Almquist International Journal of Endocrinology Volume 2013 (2013), Article ID 164939, http://dx.doi.org/10.1155/2013/164939.
  9. Temporal trends and risk factors for parathyroidectomy in the Swedish dialysis and transplant population A nationwide population-based study 1991-2009. Akaberi S, Clyne N, Sterner G, Rippe B, Reihnér E, Rylance R, Prütz KG, Almquist M.BMC Nephrol 2014 May 8:15:75.doi 10.1186/1471-2369-15-75.
  10. Management of the exterior branch of the superior laryngeal nerve among thyroid surgeons. Results from a nationwide survey. Almquist M, Nordenström E. Int J Surg 2015 Aug;20:46-51. doi: 10.1016/j.ijsu.2015.06.022. Epub 2015 Jun 11.
  11. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Ivarsson KM, Akaberi S, Isaksson E, Reihnér E, Rylance R, Prütz KG, Clyne N, Almquist M. Nephrol Dial Transplant. 2015 Dec;30(12):2027-33. doi: 10.1093/ndt/gfv334. Epub 2015 Sep 15.PMID: 26374600.
  12. Computed tomography for preoperative evaluation of need form sternotomy in surgery for retrosternal goitre. Malvemyr P, Liljeberg N, Hellström M, Muth A. Langenbeck’s Arch Surg. 2015 Apr;400(3):293-9. doi: 10.1007/s00423-014-1268-5. Epub 2015 Jan 4.
  13. Risk of recurrent laryngeal nerve palsy in patients undergoing thyroidectomy with and without intraoperative nerve monitoring. Bergenfelz A, Salem AF, Jacobsson H, Nordenström E, Almquist M; Steering Committee for the Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery (SQRTPA). Br J Surg. 2016 Aug 18. doi: 10.1002/bjs.10276.
  14. Hypoparathyroidism after total thyroidectomy in patients with previous gastric bypass. Droeser RA, Ottosson J, Muth A, Hultin H, Lindwall-Åhlander K, Bergenfelz A, Almquist M. Langenbeck’s Arch Surg. 2017 Mar;402(2):273-280. doi: 10.1007/s00423-016-1517-x. Epub 2016 Oct 26.
  15. Risk factors for complications after adrenalectomy: results from a comprehensive national database. Thompson LH, Nordenström E, Almquist M, Jacobsson H, Bergenfelz A. Langenbeck’s Arch Surg. 2017 Mar;402(2):315-322.
  16. The Effect of Parathyroidectomy on Risk of Hip Fracture in Secondary Hyperparathyroidism. Isaksson E, Ivarsson K, Akaberi S, Muth A, Sterner G, Karl-Göran P, Clyne N, Almquist M. World J Surg. 2017 Sep;41(9):2304-2311. doi: 10.1007/s00268 017-4000-0.
  17. Risk of Complications with Energy-Based Surgical Devices in Thyroid Surgery: A National Multicenter Register Study. Carlander J, Wagner P, Gimm O, Nordenström E, Jansson S, Bergkvist L, Johansson K. World J Surg. 2016 Jan;40(1):117-23.
  18. Predictors in multiglandular disease in primary hyperparathyroidism. Their M, Daudi S, Bergenfelz A, Almquist M. Langenbeck’s Arch Surgery 2018 Feb;403(1)103-109.
  19. Mortality in patients with permanent hypoparathyroidism after total thyroidectomy. Almquist M, Ivarsson K, Nordenström E, Bergenfelz A. Br J Surg. 2018 Sep;105(10):1313-1318. doi: 10.1002/bjs.10843. Epub 2018 Apr 17.
  20. A nested case-control study on the risk of surgical site infection after thyroid surgery. Salem FA, Almquist M, Nordenström E, Dahlberg J, Hessman O, Lundgren CI, Bergenfelz A. World J Surg. 2018 Aug;42(8):2454-2461. doi: 10.1007/s00268-018-4492-2.
  21. Permanent hypoparathyroidism after total thyroidectomy in children: Results from a national registry. Nordenström E, Bergenfelz A, Almquist M. World J Surg. 2018 Sep;42(9):2858-2863. doi: 10.1007/s00268-018-4552-7.
  22. Predictors of multiglandular disease in primary hyperparathyroidism. Their M, Daudi S, Bergenfelz A, Almquist M. Langenbeck’s Arch Surg 2018 Feb;403(1):103-109.
  23. Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow up of renal transplants recipients? Isaksson E, Almquist M, Seeberger A, Sterner G. Clin Exp Nephrol. 2018; Oct 22:5; 1188-1197.
  24. Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Isaksson E, Ivarsson K, Akaberi S, Muth A, Prütz KG, Clyne N, Sterner G, Almquist M. Surgery 2019 Jan 165(1):142-150.
  25. Cardiovascular and Cerebrovascular events after parathyroidectomy in patients on renal replacement therapy. Ivarsson KM, Akaberi et al  World J Surg 2019 Aug 43 (8):1981-1988.
  26. Evaluating risk factors for reexploration due to postoperative neck hematoma after thyroid surgery: a nested case control study. Salem et al. Langenbeck Arch Surg 2019.
  27. Health-related quality of life in patients undergoing adrenalectomy: report from a Swedish National audit. Thompson et al. Langenbeck’s Arch 2019.
  28. Morbidity in patients with permanent hypoparathyroidism after total thyroidectomy. Bergenfelz A, Nordenström E, Almquist M. Surgery. 2020 Jan;167(1):124-128. doi: 10.1016/j.surg.2019.06.056. Epub 2019 Sep 27.
  29. Outcome after surgery for unilateral dominant primary aldosteronism in Sweden. Sellgren F, Komán A, Nordenström E, Hellman P, Hennings J, Muth A. World J Surg. 2020 Feb;44(2):561-569. doi: 10.1007/s00268-019-05265-8.PMID: 31720794al.
  30. Complications after medullary thyroid carcinoma surgery: multicenter study of the SQRTPA and EUROCRINE databases. van Beek DJ, Almquist M, Bergenfelz AO, Musholt TJ, Nordenström E; on behalf of the EUROCRINE® Council. Br J Surg. 2020 Oct 14. doi: 10.1002/bjs.12055.
  31. Central lymph node dissection and permanent hypoparathyroidism after total thyroidectomy for papillary thyroid cancer: a population-based study. Salem FA, Bergenfelz A, Nordenström E, Almquist M.Br J Surg. 2020 Sep 16. doi: 10.1002/bjs.12028.
  32. Correlating the Bethesda system for reporting cytopathology with histology and extent of surgery: A review of 21 476 patients from four endocrine surgery registries across two continents. Inabnet WB 3rd, Palazzo F, Sosa JA, Kriger J, Aspinall S, Barczynski M, Doherty G, Iacobone M, Nordenström E, Scott-Coombes D, Wallin G, Williams L, Bray R, Bergenfelz A. World J Surg. 2020 Feb;44(2):426-435. doi: 10.1007/s00268-019-05258-7. PMID: 31690953.
  33. Invasiveness and metastatic aggressiveness in small differentiated thyroid cancers: demography of small papillary thyroid carcinomas in the Swedish population. Bayadsi H et al. World J Surg 2020 44:461–468 doi: 10.1007/s00268-019-05312-4. PMID 31834455.
  34. Impact of Adrenalectomy on Morbidity in Patients with Non-Functioning Adrenal Cortical Tumours, Mild Hypercortisolism and Cushing’s syndrome as assessed by National and Quality registers. Thompson LH, Ranstam J, Almquist M, Nordenström E, Bergenfelz A. World J Surg. 2021 Jun 27. doi: 10.1007/s00268-021-06214-0. Online ahead of print. PMID: 3418000.
  35. Adrenalectomy for incidental and symptomatic phaeochromocytoma: retrospective multicentre study based on the Eurocrine® database. Hallin -Thompson L, Makay Ö, Brunaud L, Raffaelli M, Bergenfelz A; Eurocrine Council.Br J Surg. 2021 Jul 16:znab199. doi: 10.1093/bjs/znab199. Online ahead of print. PMID: 34270711.
  36. Mortality after surgery for primary hyperparathyroidism. Results from a nationwide cohort. Nilsson M, Ivarsson K, Thier M, Nordenström E, Bergenfelz A, Almquist M.Br J Surg. 2021 Jul 23;108(7):858-863. doi: 10.1093/bjs/znab017. PMID: 33842935.
  37. Increased risk for tooth extraction in primary hyperparathyroidism and hypercalcemia: a population study. Koman A, Näsman P, Discacciati A, Ekbom A, Nilsson IL, Sandborgh-Englund G.Clin Oral Investig. 2020 Aug;24(8):2755-2761. doi: 10.1007/s00784-019-03137-y. Epub 2019 Dec 2. PMID: 31792613.
  38. Risk of Permanent Hypoparathyroidism After Total Thyroidectomy for Benign Disease: A Nationwide Population-based Cohort Study From Sweden Annebäck M, Hedberg J, Almquist M, Stålberg P, Norlén O. Ann Surg. 2021 Dec 1;274(6):e1202-e1208. doi: 10.1097/SLA.0000000000003800. PMID: 32032086.
  39. Neuropsychiatric comorbidity in primary hyperparathyroidsm before and after parathyroidectomy: a population study. Koman A, Bränström R, Pernow Y, Bränström R, Nilsson IL, Granath F.World J Surg. 2022 Jun;46(6):1420-1430. doi: 10.1007/s00268-022-06485-1. Epub 2022 Mar 5. PMID: 35246714 Free PMC article.
  40. Robot assisted versus conventional laparoscopic adrenalectomy. Results from the EUROCRINE surgical register. Vatansever S, Nordenström E, Raffaelli M, Brunaud L, Makay Ö; EUROCRINE Council. Surgery. 2022 May;171(5):1224-1230. doi: 10.1016/j.surg.2021.12.003. Epub 2022 Jan 10. PMID: 35027208.
  41. Reduced fracture incidence in patients having surgery for primary hyperparathyroidism. Nilsson M, Ståhl E, Åkesson KE, Thier M, Nordenström E, Almquist M, Bergenfelz A. Clin Endocrinol (Oxf). 2022 Sep;97(3):276-283. doi: 10.1111/cen.14703. Epub 2022 Mar 4. PMID: 35192220.
  42. Preoperative prophylactic active vitamin D to streamline total thyroidectomy. Annebäck M, McHale Sjödin E, Hellman P, Stålberg P, Norlén O.BJS Open. 2022 May 2;6(3):zrac060. doi: 10.1093/bjsopen/zrac060. PMID: 35640612 Free PMC article.
  43. Mortality after benign thyroid surgery in patients aged 80 years or older. Salem F, Bergenfelz A, Nordenström E, Nilsson M, Almquist M. Langenbecks Arch Surg. 2022 Jun;407(4):1659-1665. doi: 10.1007/s00423-022-02463-2. Epub 2022 Mar 14. PMID: 35286467; PMCID: PMC9283352.
  44. Seasonal variation in calcium treatment after thyroidectomy as surrogate for post-operative hypocalcemia: a retrospective register-based national cohort study. Kördel C, Koman A, Bränström R, Stenman A.Thyroid Res. 2022 Mar 19;15(1):5. doi: 10.1186/s13044-022-00123-7. PMID: 35305689 Free PMC article.
  45. Effects of primary hyperparathyroidism on oral health. A longitudinal register-based study. Lexomboon D, Tägt M, Nilsson IL, Buhlin K, Häbel H, Sandborgh-Englund G. Oral Dis. 2022 Nov 14. doi: 10.1111/odi.14439. Online ahead of print. PMID: 36373895.
  46. Risk factors for recurrent disease in small papillary thyroid cancers- a Swedish register-based study. Bayadsi H, Nylén C, Sandström M, Angelsten J, Sund M, Hennings J. Langenbeck’s Archives of Surgery (2023)408:162.
  47. The correlation between small papillary thyroid cancers and gamma radionuclides Cs-137, Th-232, U-238 and K-40 using spatially-explicit, register-based methods. Bayadsi H, Brink PVD, Erlandsson M, Gudbjornsdottir S, Sebraoui S, Koorem S, Nordin P, Hennings J, Englund O. Spat Spatiotemporal Epidemiol. 2023 Nov;47:100618. doi: 10.1016/j.sste.2023.100618. Epub 2023 Sep 18. PMID: 38042537.
  48. Impact of autofluorescence for detection of parathyroid glands during thyroidectomy on postoperative parathyroid hormone levels: parallel multicentre randomized clinical trial. Bergenfelz A, Barczynski M, Heie A, Muth A, Passler C, Schneider M, Wierzbicka P, Konturek A, Brauckhoff K, Elf AK, Dahlberg J, Hermann M. Br J Surg. 2023 Nov 9;110(12):1824-1833. doi: 10.1093/bjs/znad278. PMID: 37758507; PMCID: PMC10638529.
  49. Hemithyroidectomy, does the indication influence the outcome? Beka E, Hanna H, Olofsson P, Gimm O. Langenbecks Arch Surg. 2023 Dec 7;409(1):1. doi: 10.1007/s00423-023-03168-w. PMID: 38062331; PMCID: PMC10703970. 
  50. Impact of fine-needle aspiration cytology in thyroidectomy extent and associated surgical morbidity in thyroid cancer. Lind P, Nordenström E, Johansson L, Wallin G, Daskalakis K. Langenbeck’s Arch Surg. 2024 Feb 19;409(1):68. doi: 10.1007/s00423-024-03258-3. PMID: 38374242; PMCID: PMC10876808.
  51. Effect of thyroid hormone replacement therapy on mortality rate in patients undergoing total or hemithyroidectomy for benign multinodular goitre. Nordenström E, Ranstam J, Bergenfelz A. BJS Open. 2024 Jan 3;8(1):zrae012. doi: 10.1093/bjsopen/zrae012. PMID: 38372505; PMCID: PMC10875722.
  52. Regional variations in the management of primary hyperparathyroidism in Sweden: population-based case-control study. Thorsteinsson D, Granath F, Bränström R, Koman A, Zedenius J, Nilsson IL. BJS Open. 2024 Jan 3;8(1):zrad154. doi: 10.1093/bjsopen/zrad154. PMID: 38323883; PMCID: PMC10848304.
  53. Validating the risk of hypoparathyroidism after total thyroidectomy in a population-based cohort: plea for improved follow-up. Annebäck M, Osterman C, Arlebrink J, Mellerstedt S, Papathanasakis N, Wallin G, Hessman O, Annerbo M, Norlén O. Br J Surg. 2024 Jan 3;111(1):znad366. doi: 10.1093/bjs/znad366. PMID: 37995259; PMCID: PMC10776524.
  54. Surgical strategy in lithium-associated hyperparathyroidism: A population-based study. Nilsson IL, Thorsteinsson D, Nylén C, Koman A, Granath F, Bränström R. World J Surg. 2024 Feb;48(2):408-415. doi: 10.1002/wjs.12071. Epub 2024 Jan 12. PMID: 38686807.

LÄROBÖCKER

  1. Scott-Coombes D, Bergenfelz A. Endocrine Surgical Registers: Surgical outcome measurement in G Randolph: Surgery of the Thyroid and Parathyroid Glands Elsevier 2011

KONGRESSABSTRAKT

  1. Preoperativ lokalisationsundersökning hos 1792 patienter med primär HPT. Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, Lausen I. Kirurgveckan i Umeå 18-22 augusti, 2008.
  2. Hur ofta är tyreoideacancer en oväntad postoperativ diagnos? Resultat från det skandinaviska kvalitetsregistret för halskirurgi. Reihnér E, Bergenfelz A, Lausen I, Jansson S, Kristoffersson A, Mårtensson H, Wallin G. Kirurgveckan i Umeå 18-22 Augusti, 2008.
  3. Tyreoideakirurgi hos äldre patienter (Ivar Sandström föreläsning, Kirurgveckan, Göteborg 2010) Anders Bergenfelz.
  4. Risk för nervskador vid användning av värmealstrande instrument vid tyreoideakirurgi. Carlander Johan, Gimm Oliver, Nordenström Erik, Jansson Svante, Johansson Kenth. Kirurgveckan 2012 i Linköping.
  5. Lymph node surgery and thyroid cancer. Almqvist M, Kubalski L, Wallin G, Salem F, Nordenström E, (ESES Berlin 2013 och Kirurgveckan Uppsala 2013.
  6. Hur ofta är tyreoideacancer en oväntad postoperativ diagnos? Resultat från skandinaviska kvalitetsregistret för tyreoideakirurgi. Kubalski L, Bergenfelz A, Jansson S, Reihnér E, Herling T, Almquist M, Wennerberg J, Nordenström E, Wallin G. Kirurgveckan Uppsala 2013.
  7. Efficacy of preoperative diagnosis of thyroid cancer: Results as reported in a database from a multicenter audit. Reihnér E, Bergenfelz A, Lausen I, Jansson S, Kristoffersson A, Mårtensson H, Wallin G. 3rd Biennial Congress of the European Society of Endocrine Surgeons, Barcelona April 24-26. 2008.
  8. Hallgrimsson P, Almquist M, Nordenström E, Bergenfelz A. Risk factors for medically treated hypocalcemia after Surgery for Graves’ disease: a Swedish multicenter study of 1157 patients. Presenterad vid European Surgical Associations kongress i Helsingfors 2011. 
  9. Determinants for malignancy in surgically treated adrenal lesions. Wright L, Nordenström E, Almquist M. Langenbeck’s Arch Surg. 2012 Feb ;397(2):217-23. Presenterad vid ESES i Paris 2012.
  10. Reoperation for primary hyperparathyroidism. Bergenfelz A, Wallin G, Reihnér E, Jansson S, Eriksson H, Mårtensson H, Rasmussen L, Varhaug JE, Christiansen P. Presenterad vid European Society of Endocrine Surgeons Workshop 2009.
  11. Modern techniques in pHPT surgery; an evidence-based perspective. Hallgrimsson P, Almquist M, Nordenström E, Bergenfelz A. Riskfaktorer för medicinsk behandling av hypokalcemi vid Graves sjukdom: En multicenterstudie av 1157 patienter. Kirurgveckan Visby 2011.
  12. Skandinaviskt Kvalitetsregister för Tyreoidea-och Paratyreoidea Kirurgi: Resultat från kirurgisk behandling av Graves sjukdom. Bergenfelz A, Mårtensson M, Reihnér E, Jansson S, Eriksson H, Rasmussen L, Christiansen C, Varhaug H, Wallin G. Kirurgveckan i Halmstad 17–21 augusti, 2009. 
  13. Preoperativ lokalisationsundersökning hos 1792 patienter med primär HPT. Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, Lausen I. Kirurgveckan i Umeå 18–22 augusti, 2008.
  14. Lymph node surgery and thyroid cancer. Almqvist M, Kubalski L, Wallin G, Salem F, Nordenström E, (ESES Berlin 2013 och Kirurgveckan Uppsala 2013.
  15. Hur ofta är tyreoideacancer en oväntad postoperativ diagnos? Resultat från skandinaviska kvalitetsregistret för tyreoideakirurgi. Kubalski L, Bergenfelz A, Jansson S, Reihnér E, Herling T, Almquist M, Wennerberg J, Nordenström E, Wallin G. Kirurgveckan Uppsala 2013.
  16. Minimal invasiv endokrinkirurgi. Symposium Kirurgveckan 2015 i Örebro. Magnus Kjellman et al.
  17. Sekundär hyperparathyroidism. Symposium Kirurgveckan Malmö 2016.
  18. Hemi eller total tyreoidektomi för godartad struma. Symposium Kirurgveckan Jönköping 2017.
  19. Permanent hypoparathyroidism. Symposium Kirurgveckan Jönköping 2017.
  20. Permanent hypoparathyroidism hos barn efter total tyreoidektomi. Nordenström et al. Abstract Kirurgveckan 2017.
  21. Postoperativ infektion efter tyreoideakirurgi. Salem et al. Abstract Kirurgveckan 2017.
  22. Mortalitet efter permanent hypoparathyroidism. Almquist et al. Abstract Kirurgveckan 2017.
  23. Hypoparathyroidism efter tyreoidektomi – predektivt värde av PTH mätning 2 h postoperativt. Palmhag, Brännström Nilsson. Kirurgveckan Helsingborg 2018.
  24. Permanent hypoparathyroidism efter total tyreoidektomi – riskfaktorer och prevalens. Populationsbaserad registerstudie från Sverige 2005–2015 Annebäck, Stålberg, Hessman, Norlén. Kirurgveckan Helsingborg 2018.
  25. Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Isaksson et al. Kirurgveckan Helsingborg 2018.
  26. Utvärdering av 4D CT vid svårlokaliserad primär hyperparathyroidism. Åkerlund et al. Kirurgveckan 2018.
  27. Utvärdering av kirurgi som behandling vid primär aldosteronism i Sverige. Sellgern F, Koman A, Nordenström E, Hennings J, Muth A. Kirurgveckan Norrköping 2019.
  28. Ökad dödlighet efter kirurgi för primär hyperparathyroidism vid uttalad hypercalcemi. Nilsson M, Thier M, Bergenfelz A, Nordenström E, Almquist M. Kirurgveckan Norrköping 2019.
  29. Evaluating risk factors for postoperative neck hematoma after thyroid surgery. A nested case-control study. Salem F, Nordenström E, Bergenfelz A, Almquist M. Kirurgveckan Norrköping 2019.
  30. Relation between surgeon reported outcome and the National Prescribed Drug Register in Sweden. A nationwide study of permanent hypoparathyroidism after total thyroidectomy. Annebäck M et al. ESES Granada 2019.
  31. Health-related quality of life in patients undergoing adrenalectomy.  Hallin Thompson L et al. ESES Granada 2019.

DOKTORSAVHANDLINGAR

  1. Pall Hallgrimsson. Clinical problems in thyroid surgery. Lunds universitet 2014.
  2. Johan Carlander. Energy based surgical instruments with particular focus on collateral thermal injury. Linköpings Universitet 2015.
  3. Mark Thier. Controversies in the treatment of primary hyperparathyroidism. Lunds universitet 2016.
  4. Elin Isaksson. Renal hyperparathyroidism, parathyroidectomy and transplantation. Lunds universitet 2017.
  5. Lo Hallin Thompson. Clinical aspects of adrenalectomy. Lunds universitet 2021.
  6. Fahrad Salem. Complications after thyroid surgery. Lunds universitet 2021.
  7. Anna Koman. Primary hyperparathyroidism: nonclassical symptoms and benefits from parathyroidectomy. Karolinska Institutet 2021.
  8. Matilda Annebäck. Hypoparathyroidism after thyroid surgery. Rates, risks, and consequences. Uppsala universitet 2022.
  9. Haytham Bayadsi. Tumour stromal and demographical factors affecting the metastatic aggressiveness of small differentiated papillary thyroid cancers in Sweden. Umeå universitet 2023.
  10. Martin Nilsson. Impact of Surgery for Primary Hyperparathyroidism. Lunds universitet 2024.
  11. Jakob Dahlberg. On incidence, diagnostic algorithms and in-depth characterisation of thyroid cancer. Göteborgs universitet 2024.